VEGFR-1 Inhibitors Market Size, Share & Trends Analysis Report, By Drug Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and Others), By Application (Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, and Other), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Region, Forecasts, 2024-2031
VEGFR-1 Inhibitors Market Size is predicted to grow at a 7.0% CAGR during the forecast period for 2024-2031. VEGFR-1 inhibitors are essential in treating various cancers by targeting the vascular endothelial growth factor receptor-1, which is crucial for angiogenesis and tumor growth. The increasing prevalence of cancer and advancements in targeted therapies are expected to drive the adoption of VEGFR-1 inhibitors. Additionally, ongoing resear...
Report ID: 2552 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Cephalosporin API Market Size, Share & Trends Analysis Report By Product Type (First Generation, Second Generation, Third Generation, Fourth Generation), By Formulation (Oral, Injection), By Consumer Type (Hospital Use, Clinic Use, Recovery Center), By Region, And By Segment Forecasts, 2024-2031.
Cephalosporin API Market Size is valued at USD 1.70 billion in 2023 and is predicted to reach USD 2.62 billion by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031. Cephalosporin APIs are the active pharmaceutical ingredients derived from fungi, specifically Acremonium, and they form the basis of cephalosporin antibiotics like cephalexin and ceftriaxone. These APIs are crucial for treating bacterial infections and undergo r...
Report ID: 2547 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Thymidylate Synthase Inhibitor Market Size, Share & Trends Analysis Report By Type (Injection, Tablet, Others), By Application (Hospital, Clinic, Others), By Region, And By Segment Forecasts, 2024-2031.
Thymidylate Synthase Inhibitor Market Size is predicted to grow at a 6.0% CAGR during the forecast period for 2024-2031. Thymidylate synthase inhibitors disrupt DNA synthesis by blocking the enzyme thymidylate synthase. They are used primarily in cancer treatment to inhibit the growth of cancer cells, which rely on rapid DNA replication. Examples include 5-fluorouracil (administered intravenously), pemetrexed (also intravenous), and raltitrexe...
Report ID: 2549 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
cDNA Clone Vectors Market Size, Share & Trends Analysis Report By Type (Rat, Cat, Dog, Monkey, Human, Others), By Application (BioScience Companies, Hospital and Clinics, University and Institutions, Others), By Region, And By Segment Forecasts, 2024-2031.
cDNA Clone Vectors Market Size is valued at USD 120.8 Mn in 2023 and is predicted to reach USD 258.1 Mn by the year 2031 at a 10.2% CAGR during the forecast period for 2024-2031. cDNA clone vectors are tools used in molecular biology to clone and express complementary DNA (cDNA) derived from messenger RNA (mRNA). These vectors typically contain elements such as promoter regions for gene expression, selection markers for identifying successfull...
Report ID: 2544 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Vitamin B12 API Market Size, Share & Trends Analysis Report By Type (Cyanocobalamin, Hydroxocobalamin (Hydroxocobalamin Chloride, Hydroxocobalamin Acetate, Hydroxocobalamin Base), Others (Methylcobalamin, etc.)), By Form (Powder, Liquid), By Grade, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031.
Vitamin B12 API Market Size is predicted to grow at a 5.7% CAGR during the forecast period for 2024-2031. Vitamin B12(cobalamin) is a vital vitamin necessary for various important body processes, such as the creation of red blood cells as well as the synthesis of DNA. The API for vitamin B12 refers to the unadulterated form of the vitamin, typically acquired through chemical synthesis or fermentation. The active ingredient is responsible for t...
Report ID: 2536 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 179
Non-Viral Transfection Reagents Market Size, Share & Trends Analysis Distribution by Type of Non-Viral Transfection System (Non-Viral Transfection Reagents (chemical & physical), Electroporation-based Transfection Systems), Area of Application (Clinical Applications, Research Applications), End-User (Academic and Research Institutions, Pharmaceutical Companies) and Segment Forecasts, 2023-2031
Non-Viral Transfection Reagents Market Size is valued at USD 649.1 Mn in 2023 and is predicted to reach USD 1,157.5 Mn by the year 2031 at an 7.7% CAGR during the forecast period for 2024-2031. Non-viral transfection reagents represent a significant advancement in genetic manipulation techniques, offering researchers a diverse toolkit for delivering genetic material into cells. Among the several types of non-viral reagents, lipid-based formula...
Report ID: 2533 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Thermal Cyclers Market Share & Trends Analysis Report by End-user (Pharmaceutical Industries, Academic and Research Institutes, Diagnostic Laboratories), by Application, Diagnostics, Sequencing Cloning, Genotyping, Mutagenesis, Manufacturing and Quality Control Testing, Clinical Research, Forensics), by Type (Test Mesa Type, Floor Stand Type), by Product Type (Instruments, Accessories), By Region, and Segment Forecasts, 2023-2031
Thermal Cyclers Market Size is valued at USD 1.03 Bn in 2023 and is predicted to reach USD 1.86 Bn by the year 2031 at an 7.8% CAGR during the forecast period for 2024-2031. Thermal cyclers, also referred to as PCR (Polymerase Chain Reaction) machines or thermocyclers, are laboratory instruments used to amplify segments of DNA via the PCR process. They are essential tools in molecular biology, genetics, and various biological research and medic...
Report ID: 2535 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, and Others), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), By Patient Type, indication, end-user and route of administration, Region And Segment Forecasts, 2023-2031
Medical Nutrition Market Size is valued at USD 13.1 Bn in 2023 and is predicted to reach USD 20.2 Bn by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031. The escalating occurrence of malnutrition among adults and the surge in obesity rates, coupled with the increasing prevalence of chronic diseases like cancer and diabetes, are primary drivers propelling market growth. Oral clinical nutrition, comprising vitamins, proteins...
Report ID: 2525 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Cell and Gene Therapy CRO Market Size, Share & Trends Analysis Report, By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Forecasts, 2024-2031
Cell and Gene Therapy CRO Market Size was valued at USD 1.46 Bn in 2023 and is predicted to reach USD 2.43 Bn by 2031 at a 6.7% CAGR during the forecast period for 2024-2031. Cell and gene therapy involves manipulating a patient's cells to introduce, remove, or alter specific genes in order to correct genetic problems. By getting to the bottom of hereditary disorders like cystic fibrosis and cancer, this treatment approach has promise. Clinica...
Report ID: 2521 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Bioseparation Systems Market Size, Share & Trends Analysis Report, By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation and Precipitation), Application (Food, Life Sciences, Pharmaceutical and Biopharmaceutical), By Region, Forecasts, 2024-2031
Bioseparation Systems Market Size was valued at USD 5.11 Bn in 2023 and is predicted to reach USD 10.56 Bn by 2031 at a 9.7% CAGR during the forecast period for 2024-2031. The bioseparation systems market is set to experience exponential growth propelled by a convergence of factors driving demand and innovation. Technological breakthroughs, including automation and artificial intelligence advancements, are revolutionizing production processes,...
Report ID: 2523 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Pharmaceuticals